Regorafenib for the Treatment of Sarcoma Jean-Yves BlayFlorence DuffaudNicolas Penel Sarcoma (SH Okuno, Section Editor) 30 September 2022 Pages: 1477 - 1502
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies Jingqin ZhongWangjun YanYong Chen Skin Cancer (T Ito, Section Editor) Open access 01 October 2022 Pages: 1503 - 1521
Pathogenic Mechanisms in Acute Myeloid Leukemia Sohini ChakrabortyChristopher Y. Park Leukemia (PH Wiernik, Section Editor) 03 October 2022 Pages: 1522 - 1534
The Role of Autophagy in Childhood Central Nervous System Tumors Yafeng WangYiran XuChanglian Zhu Neuro-oncology (GJ Lesser, Section Editor) Open access 05 October 2022 Pages: 1535 - 1547
Treatment Options for Recurrent Primary CNS Lymphoma Leon D. KaulenJoachim M. Baehring Neuro-oncology (GJ Lesser, Section Editor) 07 October 2022 Pages: 1548 - 1565
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors Susan E. GuebleJuan C. VasquezRanjit S. Bindra Neuro-oncology (GJ Lesser, Section Editor) 15 October 2022 Pages: 1566 - 1589
Beyond Serous: Treatment Options for Rare Endometrial Cancers Erin Crane Gynecologic Cancers (JS Ferriss, Section Editor) 07 October 2022 Pages: 1590 - 1600
Therapeutic Options for Brain Metastases in Gynecologic Cancers Adeola AkapoKseniya AnishchenkoAshley L. Greenwood Gynecologic Cancers (JS Ferriss, Section Editor) 18 October 2022 Pages: 1601 - 1613
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy? Amer BeitinjanehAdrienne KaufmanMichael Wang Lymphoma (JL Muñoz, Section Editor) 13 October 2022 Pages: 1614 - 1625
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer Nicolas Girard Lung Cancer (TA Leal and N Sethakorn, Section Editors) 15 October 2022 Pages: 1626 - 1644
